Find below videos and webinars on myeloma. Click here to check full educational resources materials for all areas of work: myeloma and AL amyloidosis, access, patient evidence and capacity building and advocacy.
EHA 2025 | GIMEMA CLARITY study
Now Playing
EHA 2025 | GIMEMA CLARITY study
Myeloma Patients Europe (MPE) interviewed Francesco Sparano from ...
Myeloma Patients Europe (MPE) interviewed Francesco Sparano from Fondazione GIMEMA Franco Mandelli onlus on results from the GIMEMA-CLARITY study on the link between quality of life and socio-economic status of ...myeloma patients in Italy and the UK. The study was presented at the Euroepan Hematology (EHA) Annual Congress 2025, held in Milan, Italy.Show More
Now Playing
EHA 2025 | CARTITUDE-1
Dr. Sundar Jagannath, from the Icahn School of Medicine at Mount Sinai ...
Dr. Sundar Jagannath, from the Icahn School of Medicine at Mount Sinai in New York, USA, explains in a very simple way the important results of the CARTITUDE-1 clinical trial, ...presented at the European Hematology Association (EHA) Annual Congress 2025, held in Milan, Italy. Dr. Jagannath also explains key aspects of CARTITUDE-4, CARTITUDE-5 and CARTITUDE-6.
For more information, visit http://www.mpeurope.org.Show More
For more information, visit http://www.mpeurope.org.Show More
Now Playing
EHA 2025 | PREDATOR MRD clinical trial
Video interview with Dr. Krzysztof Giannopoulos, Medical University of ...
Video interview with Dr. Krzysztof Giannopoulos, Medical University of Lublin, Poland, summarising the main results of the clinical trial PREDADOR-MRD.
For more information, visit http://www.mpeurope.org
For more information, visit http://www.mpeurope.org
Now Playing
EHA 2025 | RedirecTT 1 clinical trial
Video-interview with Dr. Shaji Kumar about the RedirecTT-1 clinical ...
Video-interview with Dr. Shaji Kumar about the RedirecTT-1 clinical trial which evaluates talquetamab plus teclistamab in relapsed or refractory myeloma. These results were presented at the European Hematology Association Annual ...Congress 2025, in Milán, Italy.Show More
Now Playing
EHA 2025 | JNJ-5322, a novel, next generation-trispecific antibody
Video interview with Monique Minemma from the University Medical ...
Video interview with Monique Minemma from the University Medical Centre Utrecht, summarising for MPE the main results of the clinical trial of JNJ-5322, a novel next-generation trispecific antibody, presented at ...the European Hematology Association (EHA) 2025 Congress in Milan, Italy. For more information, visit http://www.mpeurope.org.Show More
Now Playing
EHA 2025 | High risk myeloma
Video interview with Dr. Martin Kaiser, Royal Marsden Hospital, ...
Video interview with Dr. Martin Kaiser, Royal Marsden Hospital, London, UK, on clinical approach to high risk myeloma, during the European Hematology Association (EHA) Annual Congress, held in Milan, Italy, ...from 12 to 15 June 2025.
Visit http://www.mpeurope.org for more informationShow More
Visit http://www.mpeurope.org for more informationShow More
Now Playing
Masterclass 2025 | Early diagnosis challenges
Video interview with Prof. Dr. Irit Avivi, Director of the Haematology ...
Video interview with Prof. Dr. Irit Avivi, Director of the Haematology Department at TASMC – Tel Aviv Sourasky Medical Centre – summarising her talk on early diagnosis challenges, given at ...the MPE Masterclass 2025, held in Warsaw, Poland, from 2–4 May.Show More
Now Playing
Masterclass 2025 | Care for carers
Prabneet Parmar, Support Group Coordinator at Myeloma UK, an MPE ...
Prabneet Parmar, Support Group Coordinator at Myeloma UK, an MPE member organisation, talks about carers' needs and how patient organisations can address them.
Now Playing
MPE Masterclass 2025 | Sequencing of myeloma treatment
Video interview filmed with Dr. Dominik Dytfeld about the talk ...
Video interview filmed with Dr. Dominik Dytfeld about the talk "Sequencing of myeloma treatment", given in the MPE Masterclass 2025, held in Warsaw, Polan, from 2-4 May.
Now Playing
MPE Masterclass 2025 | Use of AI in patient care and treatment
Adam Radziszewski, Lead Applied Scientist at Infermedica, responds our ...
Adam Radziszewski, Lead Applied Scientist at Infermedica, responds our questions about the use of Artificial Intelligence (AI) in patient care and treatment.
This recording summarises the key points from Adam’s ...talk at the MPE Masterclass 2025, held in Warsaw, Poland, from 2–4 May.Show More
This recording summarises the key points from Adam’s ...talk at the MPE Masterclass 2025, held in Warsaw, Poland, from 2–4 May.Show More
Now Playing
Ask the Expert Q&A | Living well with myeloma
Ellen Watters, Myeloma Information Specialist, Myeloma UK, responds ...
Ellen Watters, Myeloma Information Specialist, Myeloma UK, responds patients' questions about living well with myeloma. This Q&A was organised by Myeloma Patients Europe (MPE) on the occasion of the Myeloma ...Awareness Month 2025.Show More
Now Playing
Webinar EYMPG | Importance of good nutrition and healthy diet for young myeloma patients
This webinar, organised by the MPE European Young Myeloma Patient ...
This webinar, organised by the MPE European Young Myeloma Patient Group (EYMPG), was given by Inês Almada Correia, Nutritionist specialising in Oncology and Autoimmunity, from Portugal.
Now Playing
MPE webinar | Disease and treatment specificities for young myeloma patients
Recording of the webinar "Disease and treatment specificities for ...
Recording of the webinar "Disease and treatment specificities for young myeloma patients" organised by the MPE’s European Young Myeloma Patients Group. The webinar was given by Prof. Dr. Michel Delforge, ...Clinical Head of Haematology at the University Hospital UZ Leuven, Belgium, and Professor of Medicine at the KU Leuven, on 9 July 2024.Show More
Now Playing
MPE Webinar | EHA 2024 myeloma highlights
Myeloma Patients Europe (MPE) hosted a webinar on 2nd July 2024 ...
Myeloma Patients Europe (MPE) hosted a webinar on 2nd July 2024 summarising the most important myeloma updates presented at the European Hematology Association (EHA) Annual Meeting held from 13 ...of June to 16, 2024, in Madrid, Spain. Prof. Dr. Hermann Einsele, Director of the Department of Internal Medicine II at the University Hospital Würzburg, Germany, presented key updates and insights followed by a 20-minute Q&A session.Show More
Now Playing
EHA 2024 | CAMMA 2 study
Doctor Kumar explains the CAMMA 2 study presented at the 2024 European ...
Doctor Kumar explains the CAMMA 2 study presented at the 2024 European Hematology Association annual congress in Madrid, Spain.
1
of 10